LV10921A - Jaunas farmaceitiskas kompozicijas - Google Patents

Jaunas farmaceitiskas kompozicijas

Info

Publication number: LV10921A
Authority: LV; Latvia
Prior art keywords: new pharmaceutical; pharmaceutical compositions; new; methylthiazole; solvate
Prior art date: 1990-08-15

Application number

LV931024A

Other languages

English (en)

Other versions

LV10921B (en

Inventor

Bernard Robin Boar

Alan John Cross

Alfred Richard Green

Curt-Eric Hagberg

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-15

Filing date

1993-08-10

Publication date

1995-12-20

1993-08-10 Application filed by Astra Ab filed Critical Astra Ab

1995-12-20 Publication of LV10921A publication Critical patent/LV10921A/lv

1996-08-20 Publication of LV10921B publication Critical patent/LV10921B/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

LVP-93-1024A 1990-08-15 1993-08-10 Novel pharmaceutical formulations LV10921B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9002659A SE9002659D0 (sv)	1990-08-15	1990-08-15	New pharmaceutical formulations
PCT/SE1991/000522 WO1992003134A1 (en)	1990-08-15	1991-08-07	New pharmaceutical formulations of 5-(2-chloro-1-hydroxyethyl)-4-methylthiazole

Publications (2)

Publication Number	Publication Date
LV10921A true LV10921A (lv)	1995-12-20
LV10921B LV10921B (en)	1996-08-20

Family

ID=20380161

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LVP-93-1024A LV10921B (en)	1990-08-15	1993-08-10	Novel pharmaceutical formulations

Country Status (26)

Country	Link
US (1)	US5385921A (lv)
EP (1)	EP0619734B1 (lv)
JP (1)	JP3094077B2 (lv)
AT (1)	ATE164066T1 (lv)
AU (1)	AU657490B2 (lv)
BG (1)	BG97446A (lv)
CA (1)	CA2088775A1 (lv)
CZ (1)	CZ279586B6 (lv)
DE (1)	DE69129126T2 (lv)
DK (1)	DK0619734T3 (lv)
ES (1)	ES2114891T3 (lv)
FI (1)	FI930608L (lv)
HU (1)	HUT65821A (lv)
IE (1)	IE912818A1 (lv)
IL (1)	IL99169A (lv)
IS (1)	IS3743A7 (lv)
LT (1)	LT3978B (lv)
LV (1)	LV10921B (lv)
NO (1)	NO303447B1 (lv)
NZ (1)	NZ239329A (lv)
PT (1)	PT98688B (lv)
RO (1)	RO112994B1 (lv)
RU (1)	RU2093155C1 (lv)
SE (1)	SE9002659D0 (lv)
SK (1)	SK8793A3 (lv)
WO (1)	WO1992003134A1 (lv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9901658D0 (sv) *	1999-05-06	1999-05-06	Astra Ab	New formulation
SE9904177D0 (sv) *	1999-11-18	1999-11-18	Astra Ab	Novel compounds
US6699866B2 (en)	2001-04-17	2004-03-02	Sepracor Inc.	Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof
CN103772313B (zh) *	2014-01-02	2015-10-14	郑桂富	一种4-甲基-5-(2-羟乙基)噻唑的合成方法
CN112262814A (zh) *	2020-10-26	2021-01-26	宜宾学院	油樟叶渣发酵床养鸡方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2825966A1 (de) *	1978-06-14	1980-01-03	Basf Ag	Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt
GB8600783D0 (en) *	1986-01-14	1986-02-19	Merck Sharp & Dohme	N-methyl-d-aspartate receptor antagonists

1990
- 1990-08-15 SE SE9002659A patent/SE9002659D0/xx unknown
1991
- 1991-08-07 ES ES91915138T patent/ES2114891T3/es not_active Expired - Lifetime
- 1991-08-07 HU HU9300388A patent/HUT65821A/hu unknown
- 1991-08-07 DK DK91915138T patent/DK0619734T3/da active
- 1991-08-07 FI FI930608A patent/FI930608L/fi unknown
- 1991-08-07 AU AU84092/91A patent/AU657490B2/en not_active Ceased
- 1991-08-07 CZ CS93166A patent/CZ279586B6/cs unknown
- 1991-08-07 EP EP91915138A patent/EP0619734B1/en not_active Expired - Lifetime
- 1991-08-07 SK SK8793A patent/SK8793A3/sk unknown
- 1991-08-07 WO PCT/SE1991/000522 patent/WO1992003134A1/en not_active Ceased
- 1991-08-07 RO RO93-00194A patent/RO112994B1/ro unknown
- 1991-08-07 DE DE69129126T patent/DE69129126T2/de not_active Expired - Lifetime
- 1991-08-07 RU RU9193004984A patent/RU2093155C1/ru active
- 1991-08-07 AT AT91915138T patent/ATE164066T1/de not_active IP Right Cessation
- 1991-08-07 CA CA002088775A patent/CA2088775A1/en not_active Withdrawn
- 1991-08-07 JP JP03514007A patent/JP3094077B2/ja not_active Expired - Lifetime
- 1991-08-09 IE IE281891A patent/IE912818A1/en unknown
- 1991-08-09 NZ NZ239329A patent/NZ239329A/en unknown
- 1991-08-12 IL IL9916991A patent/IL99169A/en active IP Right Grant
- 1991-08-14 IS IS3743A patent/IS3743A7/is unknown
- 1991-08-14 PT PT98688A patent/PT98688B/pt not_active IP Right Cessation
- 1991-08-14 US US07/744,914 patent/US5385921A/en not_active Expired - Lifetime
1993
- 1993-02-09 NO NO930452A patent/NO303447B1/no not_active IP Right Cessation
- 1993-02-15 BG BG97446A patent/BG97446A/xx unknown
- 1993-08-10 LV LVP-93-1024A patent/LV10921B/en unknown
- 1993-12-30 LT LTIP1714A patent/LT3978B/lt not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI930608A7 (fi)	1993-02-11
LT3978B (en)	1996-06-25
CZ279586B6 (cs)	1995-05-17
HUT65821A (en)	1994-07-28
EP0619734B1 (en)	1998-03-18
HU9300388D0 (en)	1993-04-28
IS3743A7 (is)	1992-02-16
SE9002659D0 (sv)	1990-08-15
CZ16693A3 (en)	1994-02-16
RO112994B1 (ro)	1998-03-30
IE912818A1 (en)	1992-02-26
NO303447B1 (no)	1998-07-13
LV10921B (en)	1996-08-20
PT98688A (pt)	1992-07-31
DE69129126T2 (de)	1998-07-23
AU8409291A (en)	1992-03-17
SK8793A3 (en)	1993-07-07
FI930608A0 (fi)	1993-02-11
LTIP1714A (en)	1995-09-25
ES2114891T3 (es)	1998-06-16
WO1992003134A1 (en)	1992-03-05
PT98688B (pt)	1999-01-29
AU657490B2 (en)	1995-03-16
NO930452D0 (no)	1993-02-09
DE69129126D1 (de)	1998-04-23
FI930608L (fi)	1993-02-11
IL99169A0 (en)	1992-07-15
ATE164066T1 (de)	1998-04-15
BG97446A (bg)	1994-03-24
NO930452L (no)	1993-02-09
JP3094077B2 (ja)	2000-10-03
CA2088775A1 (en)	1992-02-16
IL99169A (en)	1995-10-31
EP0619734A1 (en)	1994-10-19
JPH06500097A (ja)	1994-01-06
US5385921A (en)	1995-01-31
RU2093155C1 (ru)	1997-10-20
DK0619734T3 (da)	1998-10-05
NZ239329A (en)	1994-11-25

Publication	Publication Date	Title
FI913410A7 (fi)	1992-01-24	Jatkuvasti vapauttavia farmaseuttisia koostumuksia
FI933248A0 (fi)	1993-07-16	Optiskt aktiva 5h-pyrrolo(3,4-b)pyrazinderat, dess framstaellning och farmaceutiska kompositioner innehaollande detta
FI940192A7 (fi)	1994-01-14	2-(4-hydroksipiperidino)-1-alkonolijohdannaisia verettömyyden vastaisi na aineina
FI925615A0 (fi)	1992-12-10	Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
DE69115263D1 (de)	1996-01-18	Pharmazeutische zusammensetzungen.
NZ240378A (en)	1993-12-23	Substituted thiazolidinedione derivatives; pharmaceutical compositions,
DK1199307T3 (da)	2004-06-14	Farmaceutisk aktive benzoquinazolinforbindelser
FI910088L (fi)	1991-07-10	Oral farmaceutisk komposition.
MX9200146A (es)	1992-07-01	Composiciones farmaceuticas deglutibles
DZ1576A1 (fr)	2002-02-17	Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione.
LV10921A (lv)	1995-12-20	Jaunas farmaceitiskas kompozicijas
IT1290797B1 (it)	1998-12-11	Composizioni farmaceutiche stabilizzate
FI911365L (fi)	1991-09-22	En farmaceutisk jodkomposition.
TR27833A (tr)	1995-08-31	Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
FR2674755B1 (fr)	1995-02-03	Nouvelles compositions medicamenteuses immunostimulatrices.
RU93004984A (ru)	1995-05-10	Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола
DK0511991T3 (da)	1996-11-11	Farmaceutisk formulering
LV10917A (lv)	1995-12-20	Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai
IT9022104A0 (it)	1990-11-19	Composizioni per la terapia mucolitica
FI910773A0 (fi)	1991-02-18	Farmaceutisk komposition innehaollande ett episialo-kolhydratkomplex.
FI930967A0 (fi)	1993-03-04	Substituerade 6,7-dihydroimidazo(1,5,4-ef)(1,5)bensodiazepin-6-oner, deras framstaellning och farmaceutiska kompositioner
FI930987A7 (fi)	1993-04-07	Uudet prostaglandiini-I2-johdannaiset
MX9203359A (es)	1992-09-01	Nuevas composiciones farmaceuticas de insulina.
ITMI911049A0 (it)	1991-04-16	Composizione oftalmica
IT9020563A0 (it)	1990-06-06	Derivato dell'alfa-tocoferolo solubile